Plasma Concentration of C-Reactive Protein and Risk of Ischemic Stroke and Transient Ischemic Attack: The Framingham Study | Zendy

Natalia S. Rost | Zendy; Philip A. Wolf | Zendy; Carlos S. Kase | Zendy; Margaret KellyHayes | Zendy; Halit Silbershatz | Zendy; Joseph M. Massaro | Zendy; Ralph B. D’Agostino | Zendy; Carl Franzblau | Zendy; Peter W.F. Wilson | Zendy

Open Access

Plasma Concentration of C-Reactive Protein and Risk of Ischemic Stroke and Transient Ischemic Attack: The Framingham Study

Author(s) -

Natalia S. Rost,

Philip A. Wolf,

Carlos S. Kase,

Margaret KellyHayes,

Halit Silbershatz,

Joseph M. Massaro,

Ralph B. D’Agostino,

Carl Franzblau,

Peter W.F. Wilson

Publication year - 2001

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/hs1101.098151

Subject(s) - medicine , quartile , framingham risk score , stroke (engine) , c reactive protein , diabetes mellitus , relative risk , blood pressure , cohort , cardiology , risk factor , disease , endocrinology , confidence interval , inflammation , mechanical engineering , engineering

The role of C-reactive protein (CRP) as a novel plasma marker of atherothrombotic disease is currently under investigation. Previous studies have mostly related CRP to coronary heart disease, were often restricted to a case-control design, and failed to include pertinent risk factors to evaluate the joint and net effect of CRP on the outcome. We related plasma CRP levels to incidence of first ischemic stroke or transient ischemic attack (TIA) in the Framingham Study original cohort.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research